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Abstract The aims of this study were to determine the
distribution of risk factors associated with tinnitus analys-
ing their role in the development of tinnitus and the effects
of their interaction; to evidence the importance of a suit-
able and adequate clinical and audiologic assessment to
avoid those modifiable risk factors responsible for cochlear
dysfunction and tinnitus onset. 46 subjects with tinnitus
and 74 controls were studied according to: age, sex, Body
Mass Index (BMI), neck circumference, tobacco smoking,
feeling fatigue or headache, self reporting snoring, hyper-
tension, diabetes, coronary heart disease, and/or hyperlip-
idemia, and laboratory finding as lipid profile and levels of
reactive oxygen metabolites (d-ROM). Audiological
assessment was performed by multi-frequency audiometry
(PTA0.5–16 kHz) and transient-evoked otoacoustic emissions
(TEOAE diagnostic). Univariate analysis was performed to
examine the association between determinants and
occurrence of tinnitus; Mantel–Haenszel test (G.or) was
used to investigate the joint effect of determinants on tin-
nitus. Tinnitus was more frequent among males with age
[50 years; BMI [30 kg/m2, neck circumference [40 cm,
headache, hypertension, hypercholesterolemia resulted
significant risk factors for tinnitus (P \ 0.0001). Tinnitus
group had more comorbidity (P \ 0.0001) and worse
audiometric thresholds (60.87 Vs 21.62 % hearing loss;
P \ 0.0001) with respect to control group. The interaction
between hypertension–BMI C 30 kg/m2 (G.or = 8.45) and
smoking–hypercholesterolemia (G.or = 5.08) increases
the risk of tinnitus (P \ 0.0001). Our results underline that
several factors either individually or jointly contribute to
tinnitus onset; a comprehensive knowledge about tinnitus
risk factors and associated clinical conditions could con-
tribute to minimizing this disorder.
Keywords Tinnitus  Hearing loss  Risk factors 
Multi-frequency audiometry  TEOAE
Introduction
Tinnitus is the perception of noise in the absence of an
acoustic stimulus [1]. This common condition especially in
Western societies [2–6] is usually subjective, perceived
only by the patient, and therefore, diagnosis and monitor-
ing rely on self-report.
About one-third of the population experiences tinnitus at
least once in their life and about 1–5 % develops serious
psychosocial complications; Quaranta et al. [7] evidenced a
tinnitus prevalence of 14.5 % in Italian patients (8 % in
normal hearing subjects, 30.5 % in presence of auditory
dysfunctions) while Girard et al., studying 41631 Canadi-
ans subjects, found a lower prevalence (5.2 %) [8]; in
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Germany *1.5 million people have problems with tinnitus
and 800.000 suffer so severely that they are in continuous
medical treatment [9].
The generation of an abnormal signal, which will in a
cascade of events yield the tinnitus perception, can depend
on different mechanisms [1]. In most cases the origin of
tinnitus is unknown but a close association between tinni-
tus and hearing dysfunction is well documented. Six main
pathways were recognized: (1) discordant damage of outer
(OHC) and inner (IHC) hair cells systems [1, 10–12]; (2)
crosstalk between the VIII nerve fibres [13–15]; (3) ionic
imbalance in the cochlea [11, 16, 17]; (4) dysfunction of
cochlear neurotransmitter systems [14, 16, 17]; (5) heter-
ogeneous activation of the efferent system [10, 13, 17]; (6)
heterogenous activation of Type I and II cochlear afferents
[1, 10, 13, 17].
The ‘discordant damage hypothesis’ postulates that
tinnitus is generated in the part of the basilar membrane
characterized by preserved IHCs and damaged or tempo-
rarily dysfunctional OHCs [18–20]. This hypothesis
explains the occurrence of tinnitus in patients without
hearing loss, as diffuse damage of up to 30 % of OHCs can
occur without any associated detectable hearing loss [18].
An OHC’s damage could be identified using Transient
Otoacoustic Emission (TEOAE).
In the last years many aetiological factors have been
studied and considered as potential causes of tinnitus and/
or co-factors (i.e. vascular disease, diabetes, hypertension,
autoimmune disorders, and degenerative neural disorders)
[12, 22, 23]. All these conditions could be responsible for a
periodic hypoxia/re-oxygenation with a consequent oxida-
tive stress, endothelial dysfunction, and activation of the
inflammatory cascade [24]. These noxious stimuli can
activate the sympathetic nervous system, depress para-
sympathetic activity, provoke oxidative stress and systemic
inflammation, activate platelets, and impair vascular
endothelial cochlear function.
In Italy different regional programmes are applied to
achieve the goal of an early tinnitus detection and preven-
tion and the initiatives are still left to individual hospitals.
The aim of this study was to determine the distribution
of risk factors associated with tinnitus analyzing their role
in the development of tinnitus and the effects of their
interaction; to evidence the importance of a suitable and
adequate clinical and audiologic assessment to avoid those
modifiable risk factors responsible for cochlear dysfunction
and tinnitus onset.
Materials and methods
The study was designed as a matched case–control study
on 134 subjects, 87 males and 47 females, ranging from 14
to 85 years of age, who were visited at the Audiology
Section of the Department of Bio-technology of Palermo
University.
All patients underwent careful medical history (to
identify audiological pathologies and other health diseases)
and otological examination by otolaryngologists. Subjects
with cranio-facial abnormality (CFA), syndromes associ-
ated with HL, history of ototoxic drugs administration,
otosclerosis, acoustic neuroma, chronic otitis, previous
myringotomy, ventilation tube insertion, tympanoplasty,
and coexisting psychiatric disorders were excluded from
this study.
The study protocol was completely explained to patients
and written informed consent was obtained from each
subject. The study design was approved by the Palermo
University Human Research Ethics Committee.
Data for each patient were collected regarding: age
(seven age groups: B20, from 21 to 30, 31 to 40, 41 to 50, 51
to 60, 61 to 70 and[70), sex, Body Mass Index (BMI—kg/
m2 categories: \21.0, 21.0–22.9, 23.0–24.9, 25.0–26.9,
27.0–29.9, C30), neck circumference (\40 cm; C40 cm),
tobacco smoking, feeling fatigued or headache (Yes/No)
and self reporting snoring (Yes/No). Comorbidity such as
hypertension (systolic BP [SBP] \140 mmHg or diastolic
BP [DBP] \90 mmHg, SBP 140–159 mmHg or DBP
90–99 mmHg, SBP 160–179 mmHg or DBP
100–109 mmHg, SBP C180 mmHg or DBP C110 mmHg),
diabetes (Yes/No), coronary heart disease (Yes/No), and
hyperlipidemia (lipid profile: total cholesterol level and
HDL level) were also investigated. All patients underwent
d-ROMs test that study the levels of reactive oxygen
metabolites (ROM) in blood plasma and serum. Specifically
the d-ROMs test is based on spectrophotometer studies on
increases in red colour intensity after the addition of a small
quantity of human blood to a solution of N,N-diethylpar-
aphenylendiamine (chromogen), buffered to pH 4.8. Such
colouring is attributed to the formation, via oxidation, of the
cation radical of the amine which formation is due to alk-
oxyl and peroxyl radicals. These latter derive from the
reaction of the Fe2? and Fe3? ions released by proteins in
acidic condition as created in vitro [25]. Reference values of
d-ROMs test expressed by Carratelli Units (CARR U—1
CARR U corresponds to 0.08 mg of H2O2/dL), are between
250 and 300 CARR U independently on gender and age;
values higher than 300 CARR U indicate, after a borderline
bracket (301–320 CARR U), progressively increasing lev-
els of oxidative stress: 321–340 CARR U—low level oxi-
dative stress; 341–400 CARR U—middle level of oxidative
stress; 401–500 CARR U––high level of oxidative
stress;[500 CARR U––very high level of oxidative stress
[25].
The sample was divided in two groups: subjects with
tinnitus (cases) and subjects without tinnitus (controls).
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Multi-frequency audiometry (considering the frequen-
cies 0.25–0.5–1–2–3–4–6–8–9–10–11.2–12.5–14–
16 kHz), impedenzometry and transient-evoked otoacou-
stic emissions (TEOAE diagnostic) were performed for
each ear.
Audiometric threshold was considered as the pure tone
average for the frequencies 0.5–1–2–4 kHz (PTA0.5–4 kHz)
and divided in: normal hearing (\20 dB); light hearing loss
(21–40 dB); moderate hearing loss (41–70 dB); severe
hearing loss (71–90 dB); profound hearing loss ([90 dB).
Piano Plus VRA by Inventis S.r.l. (two separate and
identical channel; frequency range: 125–8,000 Hz;
8–20 Hz) was used for testing the subjects.
TEOAE measurements were evaluated in reproducibility
(expressed as the correlation between two waveforms,
namely for responses stored in buffers A and B, acquired
alternately) and were done using defined criteria as response
detection in 4/5 different frequency bands (1, 1.5, 2, 3, and
4 kHz); a minimum signal-to-noise ratio (SNRs) of 6 dB for
each frequency band was chosen. The instrument used was
the ‘SENTIERO by Path Medical GmbH’, that is based on
the nonlinear cross-correlation method (ILO88) of TEOAE
recording. The TEOAE diagnostic was conducted by plac-
ing a small probe tip from the ‘Path Medical’ (3.9 mm
diameter 9 11.7 mm) inside the patient’s ear canal; when
powered on, the instrument initiated a routine self-calibra-
tion before recordings were made. The click rate was
approximately 97 per second and each stimulus (at the
probe loud-speaker output) consisted of a single 80 ls
square pulse. To eliminate passive mechanical artefact from
the recorded waveform, stimuli were presented in blocks of
four stimuli: three small positive polarity stimuli followed
by one big negative polarity stimulus three times as large.
Click peak stimulus level was 80 dB SPL. Emissions elic-
ited from the outer hair cells in response to the clicks were
picked up by the internal microphone of the equipment and
were windowed and filtered to remove unwanted signals; all
response data outside a window from 5 to 13 ms, after the
stimulus, were removed to eliminate the stimulus signal.
Cases compiled the Tinnitus Handicap Inventory (THI)
to evaluate the perceived severity of tinnitus and its impact
on life. This tool is a 25-item survey that is composed of
three subscales: a functional subscale (12 items), an emo-
tional subscale (8 items) and a catastrophic response sub-
scale (5 items) which address role and physical
functioning, psychological distress, desperation and loss of
control, respectively. Each item has 3 potential answers
with ‘‘yes’’ assigned 4 points, ‘‘sometimes’’ 2 points, and
‘‘no’’ 0 points. This leads to a total score ranging from 0
(indicating no tinnitus handicap) to 100 (indicating the
worst patients’ annoyance). Classically it grades five cat-
egories of tinnitus severity: slight (0–16); mild (18–36);
moderate (38–56); severe (58–76); catastrophic (78–100).
The audiologic measurements of tinnitus included pitch
masking (matching the frequency of the tinnitus with a
variety of stimuli) and loudness matching (estimating the
loudness of tinnitus with a pure tone or noise); the differ-
ence between the hearing threshold and the sensation level
was considered tinnitus loudness (0–5, 5, 10, 15, [ 15 dB
above the hearing threshold).
Statistical analysis was performed with Matlab com-
puter programme; v2 test, t test, Fisher’s exact test, logistic
odds ratio (or) and Mantel–Haenszel test were used, fol-
lowing usual conditions of application.
Results
Study sample
The patients examined were 132 but 12 subjects were
excluded from the study because of CFA (1 case), history
of ototoxic drugs administration (5 cases), otosclerosis (2
cases), chronic otitis (3 cases) and previous tympanoplasty
(1 case); 120 subjects were included in the cohort studied.
The age range of patients was from 14 to 85 years old,
with a mean age of 57.6 years ± 13.15. The 79.16 % of
subjects were [50 years old; 77 (64.16 %) patients were
males and 43 were females with a male/female ratio of 1.79
(Table 1).
Forty-six subjects (38.33 %) suffered from tinnitus; of
them, 31 were males (67.39 %) while 15 were females
(male/female ratio 2.06). Of the 74 patients of the control
group, 46 (62.16 %) were males and 28 were females with
a male/female ratio of 1.64 (P = 0.5). With mean age
values of 58.10 ± 13.28 and 57.34 ± 13.12, respectively,
for cases and controls, it resulted in no statistical difference
among the groups (P = 0.98).
Clinical characteristics
The 22.5 % (27/120) of the total cohort had a BMI value at
risk for health ([30 kg/m2); of them 21 suffered from
tinnitus while 7 were controls (Table 1). Tinnitus patients
had higher BMI values contrasting with controls, with the
43.47 % (20/46) of tinnitus group with BMI C30 with
regards to the 9.46 % (7/74) of control group (P \ 0.0001).
Even if the 74.16 % of the cohort presented a neck
circumference value\40 cm (89 subjects, 26 with tinnitus
and 63 controls), the 43.48 % of tinnitus group had a neck
circumference value C40 cm with respect to the 14.86 %
of controls (P \ 0.0001).
No statistical difference was found among the groups in
the distribution of tobacco smoking (P = 0.85).
Feeling fatigue or headache was reported by the
39.17 % (47/120) of patients; the distribution among
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Table 1 Clinical characteristics of the cohorts; tinnitus patients Vs control group: statistical analysis
Total cohort
N (%)
Tinnitus patients
N (%)
Controls N (%) Statistical analysis
120 (100) 46 (38.33) 74 (61.67) or (P) 95 %CI v2 (P)
Sex 1.26 (0.5) 0.58–2.73 0.34 (0.5)
Male 77 (64.16) 31 (67.39) 46 (62.16)
Female 43 (35.84) 15 (32.61) 28 (37.84)
Age (years)
Mean ± standard deviation 57.6 ± 13.15 58.10 ± 13.28 57.34 ± 13.12 t test = 0.3 (0.7)
Range 14–85 14–85 14–85
B50 25 (20.84) 9 (19.56) 16 (21.62) 1.13 (0.78) 0.35–2.20 0.07 (0.78)
[50 95 (79.16) 37 (80.44) 58 (78.38)
B20 2 (1.66) 1 (2.17) 1 (1.35) 0.989 (0.98)
21–30 1 (0.83) 0 (-) 1 (1.35)
31–40 9 (7.5) 3 (6.52) 6 (8.1)
41–50 13 (10.83) 5 (10.87) 8 (10.81)
51–60 51 (42.5) 19 (41.3) 32 (43.24)
61–70 29 (24.16) 12 (26.08) 17 (22.97)
[70 15 (12.5) 6 (13.04) 9 (12.16)
Body mass index (BMI) (kg/m2)
\30 93 (77.7) 26 (56.53) 67 (90.54) 7.36 (\0.0001)
2.38–19.47
18.83(\0.0001)
C30 27 (22.3) 20 (43.47) 7 (9.46)
\21.0 6 (5) – 6 (8.11) 52.4 (\0.0001)
21.0–22.9 40 (33.33) 2 (4.35) 38 (51.35)
23.0–24.9 36 (30) 16 (34.78) 20 (27.02)
25.0–26.9 3 (2.5) – 3 (4.05)
27.0–29.9 8 (6.66) 8 (17.39) –
C30 27 (22.5) 20 (43.47) 7 (9.46)
Neck circumference 4.41 (\0.0001)
1.85–10.47
12.1 (\0.0001)
\40 89 (74.16) 26 (56.52) 63 (85.14)
C40 31 (25.84) 20 (43.48) 11 (14.86)
Tobacco smoking 0.93 (0.035) 0.43–2.00 0.035 (0.85)
Yes 43 (35.87) 16 (34.79) 27 (36.49)
No 77 (64.16) 30 (65.21) 47 (63.51)
Feeling fatigued or headache 7.49 (\0.0001)
3.27–17.15
24.9 (\0.0001)
Yes 47 (39.17) 31 (67.39) 16 (21.63)
No 73 (60.83) 15 (32.61) 58 (78.37)
Self reporting snoring 3.13 (0.04) 0.98–9.99 4.01 (0.04)
Yes 99 (82.5) 42 (91.31) 57 (77.02)
No 21 (17.5) 4 (8.69) 17 (22.98)
Hypertension 12.14 (\0.0001)
5.04–29.23
35.75
(\0.0001)
Yes 48 (40) 34 (73.91) 14 (18.91)
No 72 (60) 12 (26.09) 60 (81.09)
SBP \140 mmHg or DBP \90 mmHg 72 (60) 12 (26.09) 60 (81.09)
SBP 140–159 mmHg or DBP
90–99 mmHg
14 (11.66) 10 (21.73) 4 (5.41) 36.0 (\0.0001)
SBP 160–179 mmHg or DBP
100–109 mmHg
25 (20.83) 17 (36.95) 8 (10.81)
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groups evidenced significant differences with the 67.39 %
of tinnitus group positive to this factor in respect to the
21.63 % of controls (P \ 0.0001). Also the ‘self reporting
snoring’ reported by the 82.5 % of the cohort evidenced a
higher percentage among tinnitus patients with regards to
controls (91.31 Vs 77.02 %; P = 0.04).
Hypertension was present in 73.91 % of tinnitus group
contrasting with 18.91 % of controls (P \ 0.0001) with
tinnitus patients more at risk of suffering a severe hyper-
tension (P \ 0.0001). Diabetes and coronary heart disease
were found, respectively, in the 11.66 % (14/120) and the
15 % (18/120) of the cohort without significant difference
between cases and controls (P [ 0.05).
Hypercholesterolemia resulted more frequently among
patients affected by tinnitus (47.82 %) than controls
(10.80 %) (P \ 0.0001). Particularly serum cholesterol
values C240 mg/dl were evidenced in the 15.21 and 5.4 %
of cases (mean values of 199.24 ± 48.45 mg/dl) and
control group (mean values of 166.22 ± 33.00 mg/dl),
respectively (t = 4.37; P \ 0.0001). The analysis of HDL
Table 1 continued
Total cohort
N (%)
Tinnitus patients
N (%)
Controls N (%) Statistical analysis
120 (100) 46 (38.33) 74 (61.67) or (P) 95 %CI v2 (P)
SBP C180 mmHg or DBP C110 mmHg 9 (7.5) 7 (15.21) 2 (2.70)
Diabetes 1.72 (0.33) 0.56–5.26 0.91 (0.33)
Yes 14 (11.66) 7 (15.21) 7 (9.46)
No 106 (88.34) 39 (84.79) 67 (90.54)
Coronary heart disease 0.57 (0.31) 0.19–1.73 1 (0.31)
Yes 18 (15) 5 (10.87) 13 (17.56)
No 102 (85) 41 (89.18) 61 (82.44)
Hypercholesterolemia 7.56 (\0.0001)
2.97–19.25
20.7 (\0.0001)
Yes 30 (25) 22 (47.82) 8 (10.80)
No 90 (75) 24 (52.17) 66 (94.59)
\200 mg/dl 90 (75) 24 (52.17) 66 (89.2) 21.9 (\0.0001)
200–239 mg/dl 19 (15.83) 15 (32.60) 4 (5.4)
C240 mg/dl 11 (9.16) 7 (15.21) 4 (5.4)
Total cholesterol level (mg/dl)
Mean ± standard deviation 178.75 ± 42.60 199.24 ± 48.45 166.22 ± 33.00 t test = 4.37 (\0.0001)
Range 101–315 103–315 101–250
HDL level (mg/dl)
Mean ± standard deviation 47.19 ± 12.88 45.41 ± 13.00 48.24 ± 12.85 t test = 1.16 (0.2)
Range 28 – 86 30 – 86 28 – 86
\40 mg/dl 35 (29.16) 16 (34.78) 19 (25.67) 1.54 (0.38) 0.69–3.44 1.94 (0.38)
40–59 mg/dl 60 (50) 23 (50) 37 (50)
C60 mg/dl 25 (20.84) 7 (15.21) 18 (24.32)
d-ROM test (CARR U)
Mean ± standard deviation 323.29 ± 56.87 331.11 ± 59.54 318.43 ± 55.0 t test = 1.18 (0.23)
Range 215–480 215–456 215–480
B400 105 (87.5) 38 (82.61) 67 (90.54) 2.02 (0.03) 0.68–5.99
[400 15 (12.5) 8 (17.39) 7 (9.46)
\300 CARR U 42 (35) 14 (30.43) 28 (37.84) 10.7 (0.03)
300–320 CARR U 22 (18.33) 4 (8.69) 18 (24.32)
321–340 CARR U 20 (16.66) 7 (15.22) 13 (17.57)
341–400 CARR U 21 (17.5) 13 (28.26) 8 (10.81)
401–500 CARR U 15 (12.5) 8 (17.39) 7 (9.46)
[500 CARR U – – –
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levels evidenced values C40 mg/dl (serum recommended
levels according to American Heart Association) in the
70.84 % (85/120) of the total sample (range 28–86 mg/dl);
of them 55 patients were controls (55/74, 74.32 %). Tin-
nitus patients had lower HDL levels (mean value of
45.41 ± 13.00 mg/dl) with respect to controls
Table 2 Audiological
characteristics of the cohorts:
Tinnitus population Vs Control
group: analysis statistical
a response detection in 4/5
different frequency bands with
signal-to-noise ratio (SNRs)
[6 dB HL
Total cohort
N(%)
Tinnitus
Patients (G1)
N(%)
Controls (G2)
N(%)
Statistical analysis
Hearing of
population
120 46 (38.34) 74 (61.66) v2 = 18.82 (P \ 0.0001)
or = 5.64 95 %
CI = 2.51–12.68Normal
Hearing
76 (63.33) 18 (39.13) 58 (78.38)
Hearing Loss 44 (36.67) 28 (60.87) 16 (21.62)
Bilateral 39 27 12
Unilateral 5 1 4
Hearing
threshold
120 46 74 v2 = 22.7 (P \ 0.0001)
Normal
hearing
76 (63.33) 18 (39.13) 58 (78.38)
Light HL 38 (31.66) 22 (47.82) 16 (21.62)
Moderate HL 6 (5) 6 (13.04) –
Severe HL – – –
Profound HL – – –
Hearing
threshold
mean
(dB) ± stand.
dev
t test (P)
Frequency (kHz)
0.25 18.04 ± 6.41 17.77 ± 8.43 18.2 ± 4.77 0.5 (0.61)
0.5 18.7 ± 7.31 19.51 ± 10.13 18.2 ± 4.77 1.35 (0.18)
1 19.72 ± 9.47 22.17 ± 13.75 18.2 ± 4.77 3.22 (0.001)
2 20.97 ± 10.32 24.07 ± 15.18 19.05 ± 4.56 3.76 (\0.001)
3 21.95 ± 11.48 27.47 ± 16.56 18.51 ± 3.66 6.34 (\0.001)
4 27.68 ± 13.95 37.55 ± 17.98 21.55 ± 4.19 10.39 (\0.001)
6 31.25 ± 16.46 43.04 ± 21.44 23.91 ± 3.89 10.59 (\0.001)
8 35.56 ± 21.14 53.75 ± 22.84 24.25 ± 8.27 14.29 (\0.001)
9 46.04 ± 34.08 67.17 ± 31.43 32.9 ± 28.71 8.66 (\0.001)
10 49.56 ± 34.34 71.9 ± 31.89 35.67 ± 27.94 9.24 (\0.001)
11.5 53.54 ± 35.82 80.21 ± 30.85 36.95 ± 27.84 11.22 (\0.001)
12.5 58.77 ± 39.8 92.01 ± 30.79 38.1 ± 29.45 13.55 (\0.001)
14 61.33 ± 44.36 101.52 ± 29.77 36.35 ± 31.8 15.8 (\0.001)
16 65.27 ± 46.48 111.14 ± 24.55 36.75 ± 31.69 19.21 (\0.001)
TEOAE responsesa
Invalid 52 (43.33) 23 (50) 29 (39.18) v2 = 1.35
(P = 0.24)or = 1.5595 %
CI = 0.74–3.26
Valid 68 (56.67) 23 (50) 45 (60.82)
Valid 68 (100) 23 (100) 45 (100) v2 = 1.58 (P = 0.28)
Bilateral 20 (29.41) 9 (39.13) 11 (24.44)
Monolateral 48 (70.59) 14 (60.87) 34 (75.6)
Ears (n)
Total 88 (100) 32 (100) 56 (100) v2 = 0.23 (P = 0.98)
Right 42 (47.72) 15 (46.87) 27 (48.21)
Left 46 (52.28) 16 (53.13) 29 (51.79)
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(48.27 ± 12.81 mg/dl), but without any significant differ-
ence (P = 0.24).
The study of presence/absence of comorbidity among
the patients examined evidenced that 14 cases and 30
controls resulted positive for a specific disorder. Of the 30
patients with more than 1 comorbidity, the 86.66 % were
affected by tinnitus (P \ 0.0001).
The risk of tinnitus increases 15-fold when hypertension
and BMI C30 kg/m2 coexist (G.or = 8.45); of 8 times
when subjects are smokers and affected by hypercholes-
terolemia (G.or = 5.08). Finally the risk of tinnitus
increases 3.5-fold in patients with diabetes and concomi-
tant hypercholesterolemia (G.or = 2.71).
The analysis of reactive oxygen metabolites (ROM)
levels showed mean values of 331.10 ± 59.53 CARR U
for tinnitus group and 318.43 ± 55.0 CARR U for controls
(P = 0.23). Specifically the distribution of the six catego-
ries of oxidative stress resulted normal in 30.43 and
37.83 %, borderline in 8.69 and 24.32 %, low in 15.22 and
17.57 %, middle in 28.26 and 10.81 %, high in 17.39 and
9.46 % for case and control groups, respectively
(P = 0.03).
Audiological evaluation
The 63.33 % (76/120) of the total cohort had a normal
hearing while the 36.67 % (44/120) was affected by hear-
ing loss (39 bilateral and 5 unilateral). Particularly 28
(60.87 %) patients with tinnitus were hearing impaired in
respect to 16 (21.62 %) controls (P \ 0.0001). Also the
distribution of the SNHL degree evidenced significant
differences with the 100 % of moderate SNHL subjects
belonging to tinnitus population (P \ 0.0001) (Table 2).
Multi-frequency audiometry showed a normal hearing
for the frequencies 0.25, 0.5 and 1 kHz, a slight HL for the
frequencies 2, 3, 4, 6 and 8 kHz and a moderate HL for the
frequencies 9, 10, 11.5, 12.5, 14 and 16 kHz (Fig. 1);
patients with tinnitus presented a more severe hearing
impairment, especially for high frequencies (P B 0.001).
According to the defined criteria, ‘response detection in
4/5 different frequency bands’ at SENTIERO TEOAE
diagnostic, the 56.66 % (68/120) of the total cohort pre-
sented valid TEOAE responses; of them 23 patients were
affected by tinnitus (50 % of tinnitus group) and 45 were
controls (60.82 % of control group) without significant
statistical difference among the groups (P = 0.24). Valid
responses were detected bilaterally in 9 cases and in 11
controls for a total of 32 and 56 ears, respectively, for
tinnitus and control group (P = 0.24). Figure 2 shows the
mean values, medians and range of SNRs relative to tin-
nitus and control groups; a significant difference was
observed between tinnitus population and controls with the
first group characterized by lower SNRs mean values
(P \ 0.05). Specifically 1, 1.5 and 2 kHz frequencies
resulted not impaired (SNRs ratio [6 db HL) while the 3
and 4 kHz resulted significantly impaired with a SNRs ratio
\6 dB HL.
The risk of tinnitus increases in presence of a SNHL
(P \ 0.0001) when hearing loss is associated with age
[50 years (G.or = 3.79), with hypercholesterolemia and
hypertension (G.or = 1.57), with coronary heart disease
and hypercholesterolemia (G.or = 1.57) and with diabetes,
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coronary heart disease and hypercholesterolemia
(G.or = 1.58) (Fig. 3).
Tinnitus characteristics
Tinnitus (Table 3) was referred as bilateral only in one
patient (2.18 %) and unilateral in 45 patients (97.82 %); in
the right ear in 19 subjects (41.30 %), in the left ear in 26
subjects (56.52 %).
The 84.78 % of patients reported their tinnitus as a pure
tone, instead of the 15.22 % who reported it as a narrow
band.
The tinnitus frequency, measured by the pitch-matching
test, was matched to high frequencies ([4 kHz) in 80.43 %
of cases (37/46), to middle frequencies (1–3 kHz) in the
17.39 % (8/46) of cases and not identifiable only in one
subject (2.18 %).
The loudness of tinnitus perceived by patients was:
0–5 dB above the hearing threshold in the 54.34 % of cases
(25/46), 10 dB above the hearing threshold in the 26.08 %
of cases (12/46), 15 dB above the hearing threshold in the
8.69 % of cases (4/46) and above 15 dB in the 10.86 % of
cases (5/46).
Concerning tinnitus annoyance and its impact on quality
of life, the study of THI score (mean value of
41.04 ± 21.12) evidenced a slight grade in the 15.22 % (7/
46), a mild grade in the 32.6 % (15/46); a moderate grade
in the 21.73 % (10/46) a severe grade in the 26.08 % (12/
46) and a catastrophic grade in the 4.35 % (2/46) of
patients affected by tinnitus.
No correlation between tinnitus annoyance (THI score)
and tinnitus loudness (r2 = 0.104), tinnitus frequency
(r2 = 0.0135) and hearing threshold (r2 = 0.0014) was
observed.
Discussion
Tinnitus is a multifactorial symptom, which can be induced
by all types of hearing loss as well as by clinical, somatic
disorders and pharmaceutical drugs. Axelsson and Barre-
nas described different diseases which were associated with
tinnitus and the main causes leading to tinnitus [26] such as
sex and elderly.
Many reports like those of Johansson et al. [29], Palmer
et al. [30], Fabijanska et al. [31], Martines et al. [27] and
Shargorodsky et al. [23] reported a minimally higher
prevalence for male suffering from tinnitus than for female;
it seems to be confirmed in our cohort.
Epidemiological data have generally supported a strong
association between tinnitus and increasing age; in
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particular, tinnitus affects more frequently subjects
between 61 and 70 years of age followed by patients
between 41 and 50 years of age [3, 4, 9, 27–30]. With a
prevalence of 80.44 % and a mean age of 58.10 ± 13.28,
our data evidenced the highest percentage of tinnitus after
the age of 50 years (Table 1). Therefore, the identification
of the main risk factors and co-factors of tinnitus should
help to reduce them before the age of 50 years to lower
tinnitus incidence.
In line with the literature data our results evidenced that
tinnitus in 60.87 % of cases is accompanied by SNHL
while the auditory dysfunction was present only in the
21.62 % of control group (P \ 0.0001) [2–5, 11, 14, 16,
20, 23, 27, 28]. Specifically, of the 76 subjects with normal
hearing, 58 corresponding to 76.31 % were controls
(P \ 0.001). Table 2 reports the average hearing threshold
levels for each frequency relative to tinnitus and control
groups; it is clear that patients suffering from tinnitus
presented higher hearing thresholds with respect to con-
trols, particularly for the frequencies above 4 kHz
(P \ 0.001); it confirmed that patients with tinnitus had a
worse cochlear dysfunction than control group especially
in the cochlear basal turn, where high frequencies are
represented, as suggested in CD/1 mice by Riva et al. and
Hwang et al. [24, 32].
Because SNHL and tinnitus are usually associated, it
was previously suggested that some of the factors that are
responsible for hearing loss are also responsible for the
tinnitus onset (i.e. vascular diseases, diabetes, hyperten-
sion, autoimmune disorders, and degenerative neural dis-
orders); Sindhusake et al. [21, 22], Shargorodsky et al.
[23], Lazarini et al.[33] and Nondahl et al. [34] hypothe-
sized that reduced basal and functional capillarity rare-
faction could be an additional risk factor of impaired
peripheral perfusion and dysfunction of cochlear hair cells
[21–23, 33, 34].
Our findings are in line with those from the EHLS [34]
and agree with the ‘‘clinical dictum’’ of Shargorodsky that
some clinical conditions are responsible for hearing loss
and tinnitus [23, 35]. In fact, according to Fransen et al.
who demonstrated, in a multicenter study of 2008, a strong
association between morphometric characteristics (high
body weight and high BMI score) and SNHL, we observed,
a higher BMI score and a higher neck circumference value
in patients with tinnitus than control group (P \ 0.0001)
[23, 36]; additionally, in presence of BMI C30 kg/m2 and
neck circumference C40 cm, the risk of developing tinni-
tus increases fivefold (G.or = 3.49; P = 0.003) (Fig. 3).
Fransen et al. [36–38] confirmed also the Framinghan study
(1993) and the study of Brant et al. which suggested a
strong association between SNHL, cardiovascular diseases,
high value of systolic blood pressure and hypercholester-
olemia. Shargorodsky et al., studying an American popu-
lation composed by adults with BMI C30 kg/m2,
hypertension, diabetes mellitus and dyslipidemia, demon-
strated a correlation between these disorders and tinnitus
[23]. Also our data supported these findings, with a clear
association between hypertension and/or hypercholester-
olemia and tinnitus (P \ 0.0001); the joint effect of
Table 3 Tinnitus characteristics and correlation index relative to THI
score
Factors Tinnitus populations Correlation matrix
for THI score
N (%)
Tinnitus localization r = 0.32
Unilateral right 19 (41.30)
Unilateral left 26 (56.52)
Bilateral 1 (2.18)
Head – (–)
Subjective judgment of tinnitus r = 0.29
Pure tone 39 (84.78)
Narrow band 7 (15.22)
Undetermined – (-)
Tinnitus pitch r = 0.23
High-pitched 37 (80.43)
Middle-pitched 8 (17.39)
Low-pitched – (-)
Undetermined 1 (2.18)
Tinnitus frequency (kHz) r = 0.013
1 6 (13.04)
2 2 (4.35)
4 8 (17.39)
6 10 (21.73)
8 11 (23.91)
9 2 (4.35)
10 3 (6.74)
11.2 1 (2.18)
12.5 3 (6.74)
Tinnitus loudness r = 0.10
0–5 dB 25 (54.34)
10 dB 12 (26.08)
15 dB 4 (8.69)
[15 dB 5 (10.86)
Undetermined – (–)
THI –
Mean ? standard
deviation
41.04 ± 21.12
SCORE
Slight 7 (15.22)
Mild 15 (32.60)
Moderate 10 (21.73)
Severe 12 (26.08)
Catastrophic 2 (4.35)
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hypertension and BMI C30 kg/m2 increases 15-fold the
risk of tinnitus (G.or = 8.45) (Fig. 3).
The role of smoking in the tinnitus onset is still con-
troversial. Rosenhall et al., Cruickshanks et al., Fransen
et al. and Uchida et al. found an association between
hearing levels and smoking, while on the other hand, no
association was found in the Framingham cohort [36, 37,
39–41]. From our results smoking is not a risk factor for
tinnitus (P = 0.85), even if the interaction of smoking–
hypercholesterolemia increases 8-fold the risk of develop-
ing tinnitus (G.or = 5.08; P = 0.003), as well as the risk
of tinnitus increases 3.5-fold when subjects are smokers
and suffer also from diabetes and hypercholesterolemia
(G.or = 2.71; P = 0.0001).
Recently Riva et al. and Hwang et al. [23, 32] demon-
strated, in a mouse model of age-related hearing loss (the
CD/1 mice), a higher production of reactive oxygen species
that would be responsible for cochlear degeneration through
a transient ischemia, vasospasm, thrombosis, embolism,
hypercoagulation and altered vascular characteristics in the
labyrinth. To confirm this theory, all patients underwent
d-ROM test, an oxidative stress testing that is of funda-
mental importance for preventive medicine and health care,
disease management as well as the control of relevant
therapies during pathologies. Even if a statistical difference
in the d-ROM test mean values was not found (P = 0.23), a
ROM level\320 CARR U was observed in the 62.16 % of
controls with respect to the 39.12 % of tinnitus group
(P = 0.03); it supports the role of oxidative stress as risk
factor for hearing loss and tinnitus in humans [23, 32].
Cochlear activity was also studied through TEOAE
diagnostic that gives us information relative to the normal
activity of OHCs. The choice of the TEOAE records was
taken because they are able to detect, through a reduction
of SNRs values, potential sub-clinical cochlear lesions not
evidenced at classic audiometry; from the analysis of the
TEOAE responses a valid test was evidenced only in the
50 % of tinnitus population with regards to the 60.82 % of
controls (Table 2). Moreover, Fig. 2 shows that tinnitus
subjects, presenting low mean values of SNRs, had a more
OHCs-altered functionality than controls (P = 0.0001 for
1, 1.5, 2, 3 kHz; P = 0.03 for 4 kHz).
The effects of tinnitus on quality of life are highly
individualized, so that personality characteristics may
predispose some people to experience tinnitus as a ‘‘dis-
tressing’’ symptom. The 30.43 % of patients affected by
tinnitus has sleep disturbances and difficulty with any daily
activity while no significant correlation was found between
the level of tinnitus intensity measured by matching pro-
cedure and the tinnitus annoyance. It may support the
actual theory that the patient’s reaction to tinnitus cannot
be classified as a simple function of its psychoacoustic
aspects but rather as a complex interaction between
acoustic phantom symptoms, somatic attention and
depressive symptoms; moreover, the subjective judgment
of tinnitus intensity was C10 dB above the hearing
threshold in the 45.63 % of tinnitus group, suggesting that
most patients seek for specialist examination when the
symptom is already disturbing [42, 43].
Conclusions
Because tinnitus and SNHL are often associated disorders,
it is reasonable that factors responsible for hearing loss are
also likely to have caused tinnitus; our data suggest that
several factors either individually or jointly are associated
with tinnitus. Ageing, BMI[30 kg/m2, high values of neck
circumference, hypertension and hypercholesterolemia are
significantly associated with tinnitus; the effect of smoking
becomes significant when associated with hypercholester-
olemia; the joint effects of [2 medical disorders increases
significantly the risk of tinnitus (i.e.: 15-fold when coex-
isting hypertension and BMI[30 kg/m2, G.or = 8.45; 3.5-
fold in smokers with concomitant diabetes and hypercho-
lesterolemia G.or = 2.71).
Comprehensive knowledge of tinnitus risk factors could
assist in the management of tinnitus, as well as providing a
solid research evidence base for the delivery of tinnitus-
related healthcare. These data are also needed to guide
policy decisions that shape public health practice in rela-
tion to tinnitus treatment and management. It is possible
that timely health interventions to reduce or limit exposure
to specific environmental/lifestyle factors and/or better
managing conditions such as age-related hearing loss could
reduce the incidence of tinnitus. Education and guidance
on the modifiable risk factors found in this study could
contribute to minimizing this condition in populations.
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